Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 298.29
-13.32 (-4.27%)
At close: Oct 3, 2025
Cencora Market Cap
Cencora has a market cap or net worth of 43.56 billion as of October 3, 2025. Its market cap has increased by 28.44% in one year.
Market Cap
43.56B
Enterprise Value
49.60B
Revenue
231.13B
Ranking
n/a
PE Ratio
31.45
Stock Price
298.29
Market Cap Chart
Since April 4, 1995, Cencora's market cap has increased from 199.85M to 43.56B, an increase of 21,694.71%. That is a compound annual growth rate of 19.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 43.56B | 25.57% |
| Dec 31, 2024 | 34.69B | 8.10% |
| Dec 29, 2023 | 32.09B | 15.46% |
| Dec 30, 2022 | 27.79B | 36.06% |
| Dec 31, 2021 | 20.43B | 39.67% |
| Dec 31, 2020 | 14.62B | 10.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.12B |
| GSK plc | 66.29B |
| Haleon | 29.39B |
| Smith & Nephew | 11.60B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.06B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |